BRCA2 PROTAC(First Affiliated Hospital of Xi'an Jiaotong University)

Cancer Res[Jour] AND 85[volume] AND 13[issue] 癌症研究 85卷 13期 https://aacrjournals.org/cancerres/issue/ Editorial(社论) 1 Cancer Research in the Age of Big Data 大数据时代的癌症研究 Christine A. Iacobuzio-Donahue Cancer Res (2025) 85 (13): 2347 In the Spotlight(焦点) 2 Leveraging Whole-Exome Sequencing and Mutational Signatures to Detect Homologous Recombination Deficiency in Cancer 利用全外显子组测序和突变特征检测癌症同源重组缺陷 Joonoh Lim; Young Seok Ju Cancer Res (2025) 85 (13): 2348–2350 3 Cells Keep Diverse Company in Diseased Tissues 细胞在疾病组织中保持多样性 Kieran R. Campbell; Aleksandrina Goeva Cancer Res (2025) 85 (13): 2351–2352 Cancer Research Landmarks(癌症研究里程碑) 4 Paving a Path to Clinical Impact with Radiomics: Enabling Reproducibility and Reach 为放射组学的临床影响铺平道路：实现可重复性和可及性 Mohamad El-Jammal; Caroline Chung Cancer Res (2025) 85 (13): 2353–2355 Reviews(综述) 5 Artificial Intelligence–Driven Cancer Diagnostics: Enhancing Radiology and Pathology through Reproducibility, Explainability, and Multimodality 人工智能驱动的癌症诊断：通过可再现性、可解释性和多模态增强放射学和病理学 Pegah Khosravi; Thomas J. Fuchs; David Joon Ho Cancer Res (2025) 85 (13): 2356–2367 6 Illuminating the Noncoding Genome in Cancer Using Artificial Intelligence 利用人工智能阐明癌症中的非编码基因组 Maria del Mar Alvarez-Torres; Xi Fu; Raul Rabadan Cancer Res (2025) 85 (13): 2368–2375 7 Leveraging Artificial Intelligence for Neoantigen Prediction 利用人工智能进行新抗原预测 Jing Zeng; Zhengjun Lin; Xianghong Zhang; Tao Zheng; Haodong Xu; Tang Liu Cancer Res (2025) 85 (13): 2376–2387 Cancer Biology(癌症生物学) 8 Dissecting FAP+ Cell Diversity in Pancreatic Cancer Uncovers an Interferon-Response Subtype of Cancer-Associated Fibroblasts with Tumor-Restraining Properties 剖析胰腺癌中FAP+细胞多样性揭示具有肿瘤抑制特性的癌症相关成纤维细胞干扰素应答亚型 Joshua Cumming; Parniyan Maneshi; Mitesh Dongre; Tala Alsaed; Mohammad Javad Dehghan-Nayeri; Agnes Ling; Kristian Pietras; Cedric Patthey; Daniel Öhlund Cancer Res (2025) 85 (13): 2388–2411 9 Targeting LTBP2 Derived from Cancer-Associated Fibroblasts Sensitizes Esophageal Squamous Cell Carcinoma to Chemotherapy 靶向来自癌症相关成纤维细胞的LTBP2使食管鳞状细胞癌对化疗敏感 Jiarong Zhan; Mengqing Li; Lei Li; Ting-Ting Zeng; Jun Liu; Qingyun Chen; Chen Jiang; Xin Wang; Dan Xie; Xin-Yuan Guan; Ying-Hui Zhu Cancer Res (2025) 85 (13): 2412–2428 10 Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression 慢性应激刺激前体巨噬细胞极化促进肺癌进展 Cuilan Liu; Hengwei Du; Guoxing Yu; Jingjing Qi; Hongliang Dong; Ruiqi Hu; Fei Wang; Bingjie Cui; Weiwei Chen; Qian Zhang; Chen Li; Ran Gao; Clemens A. Schmitt; Jiong Deng; Yong Yu; Jing Du Chronic stress facilitates lung cancer immune evasion by inducing M2-like macrophage polarization, supporting the potential of combination therapies targeting both tumor cells and the immune microenvironment for treating stress-related cancers. Cancer Res (2025) 85 (13): 2429–2447 Cancer Immunology(癌症免疫学) 11 Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin 氨通过降低成熟穿孔素抑制自然杀伤细胞和T细胞的抗肿瘤活性 Joanna Domagala; Tomasz M. Grzywa; Iwona Baranowska; Magdalena Justyniarska; Ryan Tannir; Agnieszka Graczyk-Jarzynka; Aleksandra Kusowska; Maria Lecka; Marcin Poreba; Klaudyna Fidyt; Katsiaryna Marhelava; Zofia Pilch; Lea K. Picard; Tomasz Wegierski; Kamil Jastrzebski; Marta Krawczyk; Marta Klopotowska; Monika Granica; Doris Urlaub; Szymon Hajduk; Alexandra Neeser; Spencer Moros; Pawel Kozlowski; Malgorzata Bobrowicz; Marta Miaczynska; Leyuan Ma; Carsten Watzl; Magdalena Winiarska Cancer Res (2025) 85 (13): 2448–2467 12 Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites 甘露糖通过调节肠道微生物代谢物提高卵巢癌免疫治疗效果 Chen Zhang; Yiying Wang; Mengdi He; Chenyang Wang; Kankan Cao; Yujing Zhong; Xueling Wang; Moran Yang; Guodong Zhang; Jiaqi Lu; Huan Yi; Haiou Liu; Congjian Xu Cancer Res (2025) 85 (13): 2468–2484 Translational Cancer Biology(癌症转化生物学) 13 SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma SCD1抑制阻断AKT-NRF2-SLC7A11通路诱导肺腺癌脂质代谢重塑和铁蛋白沉积 Utsav Sen; Charles Coleman; Nishant Gandhi; Vrinda Jethalia; Deniz Demircioglu; Andrew Elliott; Ari M. Vanderwalde; Omar Hayatt; Elisa de Stanchina; Balazs Halmos; Patrick C. Ma; Mirela Berisa; Dan Hasson; Triparna Sen Cancer Res (2025) 85 (13): 2485–2503 Computational Cancer Biology and Technology(癌症计算生物学与技术) 14 HRProfiler Detects Homologous Recombination Deficiency in Breast and Ovarian Cancers Using Whole-Genome and Whole-Exome Sequencing Data HRProfiler使用全基因组和全外显子组测序数据检测乳腺癌和卵巢癌的同源重组缺陷 Ammal Abbasi; Christopher D. Steele; Erik N. Bergstrom; Azhar Khandekar; Akanksha Farswan; Rana R. McKay; Nischalan Pillay; Ludmil B. Alexandrov Cancer Res (2025) 85 (13): 2504–2513 15 Combining Spatial Transcriptomics, Pseudotime, and Machine Learning Enables Discovery of Biomarkers for Prostate Cancer 将空间转录组学、伪时间和机器学习相结合，有助于发现癌症前列腺生物标志物 Martin Smelik; Daniel Diaz-Roncero Gonzalez; Xiaojing An; Rakesh Heer; Lars Henningsohn; Xinxiu Li; Hui Wang; Yelin Zhao; Mikael Benson Cancer Res (2025) 85 (13): 2514–2526 16 Multitask Deep Learning Based on Longitudinal CT Images Facilitates Prediction of Lymph Node Metastasis and Survival in Chemotherapy-Treated Gastric Cancer 基于纵向CT图像的多任务深度学习有助于预测癌症化疗后淋巴结转移和存活率 Bingjiang Qiu; Yunlin Zheng; Shunli Liu; Ruirui Song; Lei Wu; Cheng Lu; Xianqi Yang; Wei Wang; Zaiyi Liu; Yanfen Cui Cancer Res (2025) 85 (13): 2527–2536 Convergence Science(融合医学) 17 Eco-Evolutionary Guided Pathomic Analysis Detects Biomarkers to Predict Ductal Carcinoma In Situ Upstaging 生态进化指导的病理分析检测生物标志物以预测导管癌原位升级 Yujie Xiao; Manal Elmasry; Ji Dong K. Bai; Andrew Chen; Yuzhu Chen; Brooke Jackson; Joseph O. Johnson; Prateek Prasanna; Chao Chen; Mehdi Damaghi Evolutionary dynamics of the various niches composing the tumor ecosystem can be harnessed for predicting cancer progression, demonstrating how eco-evolutionary–designed approaches can guide biomarkers discovery studies in the era of digital pathology Cancer Res (2025) 85 (13): 2537–2547 Cancer Res[Jour] AND 85[volume] AND 14[issue] 癌症研究85卷 14期 https://aacrjournals.org/cancerres/issue/ In the Spotlight(焦点) 1 Pan-Cancer Spatial Profiling Reveals Conserved Subtypes and Niches of Cancer-Associated Fibroblasts 泛癌症空间谱揭示了癌症相关成纤维细胞的保守亚型和生态位 Hani Jieun Kim; Travis Ruan; Alexander Swarbrick Cancer Res (2025) 85 (14): 2555–2557 In Focus(焦点) 2 Bacterial Therapeutics: Addressing the Affordability Gap in Cancer Therapy 细菌疗法：解决癌症治疗的可负担性差距 Kejsi Prifti; Chiswili Yves Chabu; Koichi S. Kobayashi; Jianxun Song; Arum Han; Paul de Figueiredo Cancer Res (2025) 85 (14): 2558–2560 Review(综述) 3 AXL Tyrosine Kinases: A Growing Isoform Family That Promotes Cancer Pathogenesis AXL酪氨酸激酶：促进癌症发病的一个不断增长的异构体家族 May Eriksen Gjerstad; Pia Aehnlich; Pascal Gelebart; Emmet Mc Cormack Cancer Res (2025) 85 (14): 2561–2573 Cancer Biology(癌症生物学) 4 The Integrated Stress Response Pathway Coordinates Translational Control of Multiple Immune Checkpoints in Lung Cancer 综合应激反应途径协调肺癌中多个免疫检查点的转化控制 Shayna Thomas-Jardin; Shruthy Suresh; Ariana Arce; Nicole Novaresi; Qing Deng; Emily Stein; Lisa Thomas; Cheryl Lewis; Chul Ahn; Bret M. Evers; Esra A. Akbay; Maria E. Salvatierra; Wei Lu; Khaja Khan; Luisa M. Solis Soto; Ignacio I. Wistuba; John D. Minna; Kathryn A. O’Donnell Cancer Res (2025) 85 (14): 2574–2590 5 Cis-Regulatory Alterations in FOXP4 Modulate Esophageal Cancer Susceptibility Induced by Chronic Alcohol Exposure FOXP4顺式调控改变可调节慢性酒精暴露诱导的食管癌易感性 Siyuan Niu; Jialing Ma; Shasha Liu; Yueping Li; Xinying Yue; Miaoxin Pan; Lina Song; Yutong Wu; Zifei Yang; Yuqian Tan; Linglong Gu; Chaolong Wang; Jiang Chang Cancer Res (2025) 85 (14): 2591–2607 6 Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness 原位细胞系来源的异种移植物的大规模表征鉴定TGFβ信号作为乳腺癌形态和侵袭性的关键调节因子 Catrin Lutz; Xue Chao; Bim de Klein; Jinhyuk Bhin; Madelon Badoux; Timo Eijkman; Apostolos P. Nikolakopoulos; Stefan J. Hutten; Natalie Proost; Bjørn Siteur; Marieke van de Ven; Ji-Ying Song; Jacco van Rheenen; Jessica Morgner; Stefan Prekovic; Jos Jonkers Cancer Res (2025) 85 (14): 2608–2625 7 Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type SMARCA4的缺失导致高钙血症型卵巢小细胞癌内含子保留和肿瘤相关抗原的产生 Elizabeth A. Raupach; Apurva M. Hegde; Krystine Garcia-Mansfield; Marice Alcantara; David L. Rose; Rebecca F. Halperin; Krystal A. Orlando; Jessica D. Lang; Ritin Sharma; Victoria David-Dirgo; Salvatore J. Facista; Rayvon Moore; Rochelle Kofman; Zoe N. Jensen; Victoria L. Zismann; Anthony N. Karnezis; Yemin Wang; Lynda B. Bennett; Timothy G. Whitsett; Marcin Kortylewski; William P.D. Hendricks; David G. Huntsman; Lorna Rodriguez-Rodriguez; Bernard E. Weissman; Jeffrey M. Trent; Patrick Pirrotte Cancer Res (2025) 85 (14): 2626–2642 Cancer Immunology(癌症免疫学) 8 Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy 缺铁性巨噬细胞激活CD8+T细胞以刺激抗肿瘤免疫并提高免疫治疗效果 Brian J. Laight; Danielle Harper; Natasha Dmytryk; Connie S. Zhang; Changnian Shi; Andrew Garven; Richard W. Nauman; Jacob Kment; Faizah Alotaibi; Ivan Shapovalov; Victoria Hoskin; Yan Gao; Jeffery Mewburn; Caitlyn Vlasschaert; Ami Wang; Julian Simonetti; David LeBrun; Kathrin Tyryshkin; David M. Berman; Amber L. Simpson; Charles H. Graham; Andrew W. Craig; Sameh Basta; Madhuri Koti; Peter A. Greer Cancer Res (2025) 85 (14): 2643–2658 9 Antigen Cross-Presentation by Type-2 Innate Lymphoid Cells Facilitates the Activation of Antitumor CD8+ T Cells 2型先天淋巴细胞的抗原交叉呈递促进了抗肿瘤CD8+ T细胞的激活 Jihyun Kim; Seung Geun Song; Suhyun Park; Young Gyun Ko; Jongho Ham; TaeSoo Kim; Sang-Jun Ha; Yong-Soo Bae; Doo Hyun Chung; Hye Young Kim Cancer Res (2025) 85 (14): 2659–2678 10 Targeting Intracellular Innate RNA-Sensing Systems Overcomes Resistance to CAR T-cell Therapy in Solid Tumors 靶向细胞内天然RNA传感系统克服实体瘤对CAR-T细胞治疗的耐药性 Nardine Soliman; Tatiana Nedelko; Giada Mandracci; Stefan Enssle; Vincent Grass; Julius C. Fischer; Florian Bassermann; Hendrik Poeck; Sebastian Kobold; Nadia El Khawanky; Simon Heidegger Cancer Res (2025) 85 (14): 2679–2693 Cancer Metabolism and Molecular Mechanisms(癌症代谢与分子机制) 11 Aberrant CircTMEM45A Facilitates Inflammatory Progression of Esophageal Squamous Cell Carcinoma through m5C-Mediated NLRP3 Activation 异常CircTMEM45A通过m5c介导的NLRP3激活促进食管鳞状细胞癌的炎症进展 Lingjiao Meng; Haotian Wu; Jiaxiang Wu; Ping’an Ding; Jinchen He; Tongkun Li; Xiaoman Niu; Meixiang Sang; Lihua Liu Cancer Res (2025) 85 (14): 2694–2713 Therapeutic Development and Chemical Biology(治疗学发展和生物化学) 12 A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy 蓝藻衍生的RNA适体使前列腺癌对激素治疗重新敏感 Carlos D. Cruz-Hernández; Bethany Smith; Sandrine Billet; Manish Thiruvalluvan; Gabrielle Gonzales; David M. Underhill; Ekihiro Seki; Shelly C. Lu; Neil A. Bhowmick Cancer Res (2025) 85 (14): 2714–2725 Translational Cancer Biology(癌症转化生物学) 13 Genomic and Single-Cell Analyses Characterize Patient-Derived Tumor Organoids to Enable Personalized Therapy for Head and Neck Squamous Cell Carcinoma 基因组和单细胞分析表征患者来源的肿瘤类器官，以实现头颈部鳞状细胞癌的个性化治疗 Jung Hyun Um; Yueyuan Zheng; Qiong Mao; Chehyun Nam; Hua Zhao; Yoon Woo Koh; Su-Jin Shin; Young Min Park; De-Chen Lin Cancer Res (2025) 85 (14): 2726–2742 14 Integration of Germline and Somatic Variation Improves Chronic Lymphocytic Leukemia Risk Stratification 种系和体细胞变异的整合提高了慢性淋巴细胞白血病的风险分层 Aubrey K. Hubbard; Derek W. Brown; Jie Liu; Irenaeus C. Chan; Weiyin Zhou; Giulio Genovese; Alexander DePaulis; Sruthi Srinivasan; Shu-Hong Lin; Batel Blechter; Ian D. Buller; Qinglin Zeng; Yin Cao; Wen-Yi Huang; Neal D. Freedman; Haoyu Zhang; Diptavo Dutta; Stephen J. Chanock; Kelly L. Bolton; Mitchell J. Machiela Cancer Res (2025) 85 (14): 2743–2752 Computational Cancer Biology and Technology(癌症计算生物学与技术) 15 A Machine Learning–Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia 基于机器学习的策略预测复发急性髓性白血病的选择性和协同药物组合 Yingjia Chen; Liye He; Aleksandr Ianevski; Kristen Nader; Tanja Ruokoranta; Nora Linnavirta; Juho J. Miettinen; Markus Vähä-Koskela; Ida Vänttinen; Heikki Kuusanmäki; Mika Kontro; Kimmo Porkka; Krister Wennerberg; Caroline A. Heckman; Anil K. Giri; Tero Aittokallio Cancer Res (2025) 85 (14): 2753–2768 Cancer Res[Jour] AND 85[volume] AND 15[issue] 癌症研究85卷 15期 https://aacrjournals.org/cancerres/issue/ In the Spotlight(焦点) 1 Ferreting Out Ferroptosis: Extending the Mechanism of Action of RSL3 to the Selenoproteome in Colorectal Cancer 摆脱脱铁症：将RSL3的作用机制扩展到结直肠癌的硒蛋白组 Sarah P. Short Cancer Res (2025) 85 (15): 2775–2777 2 Unlocking the Therapeutic Potential of the cGAS–STING Pathway through TREX1 Targeting 通过TREX1靶向释放cGAS-STING通路的治疗潜力 Brent A. Hanks Cancer Res (2025) 85 (15): 2778–2780 3 The Genetic Footprint of Tobacco Smoking: Unraveling the Mutational Signatures in Head and Neck Cancer 吸烟的遗传足迹：揭示头颈癌的突变特征 Kaito Mimura; Kenichi Yoshida Cancer Res (2025) 85 (15): 2781–2783 In Focus(焦点) 4 Charting New Paths in Cancer Research: Insights from the Frontiers in Cancer Science Conference 2024 绘制癌症研究的新路径：来自2024年癌症医学会议前沿的见解 Giang Le Minh; Sasidharan Swarnalatha Lucky; Shazib Pervaiz; Kristijan Ramadan; Joe Yeong; Sin Tiong Ong; Vaidehi Krishnan; Chit Fang Cheok; Wee Joo Chng; Sanjay De Mel; Xiaomeng Wang; Anand D. Jeyasekharan; Chartsiam Tipgomut; Li Ren Kong; Kanaga Sabapathy; Cheng Ean Chee; Koji Itahana; Reshma Taneja; Soo-Chin Lee Cancer Res (2025) 85 (15): 2784–2787 Cancer Biology(癌症生物学) 5 Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer RSL3肿瘤抑制机制的重新表征确定硒蛋白组作为结直肠癌的可药物途径 Stephen L. DeAngelo; Liang Zhao; Sofia Dziechciarz; Myungsun Shin; Sumeet Solanki; Andrii Balia; Marwa O. El-Derany; Cristina Castillo; Yao Qin; Nupur K. Das; Hannah N. Bell; Joao A. Paulo; Yuezhong Zhang; Nicholas J. Rossiter; Elizabeth C. McCulla; Jianping He; Indrani Talukder; Billy Wai-Lung Ng; Zachary T. Schafer; Nouri Neamati; Joseph D. Mancias; Markos Koutmos; Yatrik M. Shah Cancer Res (2025) 85 (15): 2788–2804 6 Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression 胰腺神经内分泌肿瘤分泌载脂蛋白E诱导尖端内皮细胞重塑肿瘤-间质比率并促进肿瘤进展 Xin Lou; Yihua Shi; Faming Zhao; Xiaowu Xu; Yan Wang; Yi Qin; Wuhu Zhang; Zeng Ye; Fei Wang; Tian Ding; Desheng Jing; Guixiong Fan; Yue Zhang; Xuemin Chen; Jie Chen; Xianjun Yu; Junfeng Xu; Shunrong Ji Cancer Res (2025) 85 (15): 2805–2819 7 Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia PAX5P80R突变建模揭示HIF2α激活是B细胞急性淋巴细胞白血病的共同特征和治疗靶点 Manon Bayet; Vincent Fregona; Mathieu Bouttier; Clémence Rouzier; Jérémy Bigot; Laura Jamrog; Sylvie Hebrard; Naïs Prade; Stéphanie Lagarde; Christine Didier; Stéphanie Gachet; Marie Passet; Laetitia Largeaud; Marlène Pasquet; Ahmed Amine Khamlichi; Emmanuelle Clappier; Eric Delabesse; Cyril Broccardo; Bastien Gerby Cancer Res (2025) 85 (15): 2820–2837 8 Tobacco Smoking Rewires Cell Metabolism by Inducing GAPDH Succinylation to Promote Lung Cancer Progression 吸烟通过诱导GAPDH琥珀酰化改变细胞代谢促进肺癌进展 Kun Wang; Jingzhuo Li; Hai Zhang; Hongyan Ma; Hong-Yong Cui; Huai-Qiang Ju; Jing Zhang; Qing-zhi Ma; Ming Zhao; Qing-mei Zeng; Jie Zou; Xiu-Xuan Sun; Gang Nan; Meirui Qian; Lin Jing; Yiming Li; Cai-feng Xiong; Qiu-zi Yang; Hao Wang; Jian-Li Jiang; Zhi-Nan Chen; Liang Chen; Wan Huang Cancer Res (2025) 85 (15): 2838–2857 Cancer Immunology(癌症免疫学) 9 Targeting Innate Immune Checkpoint TREX1 Is a Safe and Effective Immunotherapeutic Strategy in Cancer 靶向先天免疫检查点TREX1是一种安全有效的癌症免疫治疗策略 Cong Xing; Xintao Tu; Wanwan Huai; Zhen Tang; Kun Song; Devon Jeltema; Kennady Knox; Nicole Dobbs; Kun Yang; Nan Yan Cancer Res (2025) 85 (15): 2858–2875 10 Systemic Inactivation of TREX1 Induces Selective Inflammation of the Tumor Microenvironment and Invigorated T-cell–Mediated Tumor Control TREX1的系统失活诱导肿瘤微环境的选择性炎症和活化T细胞介导的肿瘤控制 Emilija Marinkovic; Minyi Chen; Nadja Schubert; Elif Dogan Dar; Tanja Poth; Janet Y. Leung; Jack Lohre; Jennifer M. Sahni; Christine Tun; Pavithra Rajeswaran; Tanja Mehlo-Jensen; Olivia Perng; C. Mark Hill; Pallavur Sivakumar; Michael J. Barnes; Rohit Malik; Rayk Behrendt; Axel Roers Cancer Res (2025) 85 (15): 2876–2889 Therapeutic Development and Chemical Biology(治疗学发展和生物化学) 11 Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells 结合多重CRISPR/Cas9-Nickase和PARP抑制剂有效精确地靶向癌细胞 Soyoung Lee; Kyunghwan Kim; Hye-Jin Jeong; Subin Choi; Himchan Cheng; Dayoung Kim; Soomin Heo; Jinhee Mun; Minjong Kim; Eunjin Lee; Yoon Ji Choi; Seon-gyeong Lee; Eun A Lee; Yewon Jang; Kayeong Lim; Heon Seok Kim; Euihwan Jeong; Seung-Jae Myung; Deok-Beom Jung; Chang Sik Yu; In Ho Song; M. Ryan Corces; Joo H. Kang; Kyungjae Myung; Taejoon Kwon; Tae-Eun Park; Jinmyoung Joo; Seung Woo Cho Cancer Res (2025) 85 (15): 2890–2904 Cancer Landscapes(癌症特征) 12 Comprehensive Characterization of Somatic Mutation Timing Reveals the Evolutionary Trajectory of Lung Adenocarcinoma in Chinese Patients 体细胞突变时间的综合表征揭示了中国患者肺腺癌的进化轨迹 Na Qin; Zhoufeng Wang; Xianfeng Xu; Yuan Xie; Yingjia Chen; Wenxin Luo; Pan Tang; Xin Wang; Lingfeng Bi; Linnan Gong; Zhe Li; Congcong Chen; Kai Wang; Songwei Guo; Zihuan Zhao; Jun Xiang; Meng Zhu; Yue Jiang; Yuanlin He; Juncheng Dai; Rong Yin; Cheng Wang; Zhibin Hu; Hongxia Ma; Weimin Li; Hongbing Shen Cancer Res (2025) 85 (15): 2905–2920 Computational Cancer Biology and Technology(癌症计算生物学与技术) 13 Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm 细胞可塑性的表观遗传力通过一对多基因型-表型范式驱动癌症耐药性 Erica A. Oliveira; Salvatore Milite; Javier Fernandez-Mateos; George D. Cresswell; Erika Yara-Romero; Georgios Vlachogiannis; Bingjie Chen; Chela T. James; Lucrezia Patruno; Gianluca Ascolani; Ahmet Acar; Timon Heide; Inmaculada Spiteri; Alex Graudenzi; Giulio Caravagna; Andrea Bertotti; Trevor A. Graham; Luca Magnani; Nicola Valeri; Andrea Sottoriva Cancer Res (2025) 85 (15): 2921–2938 Convergence Science(融合医学) 14 Tumor Suppressor Genes with Segmental Duplications Are Prone to Somatic Deletions and Structural Variations 具有片段重复的肿瘤抑制基因容易发生体细胞缺失和结构变异 Ziheng Huang; Lin Zhang; Huarong Chen; Xiaodong Liu; Likai Tan; Dan Huang; Yingzhi Liu; Yushan Wang; Xinyi Zhang; Alfred Sze Lok Cheng; Maggie Haitian Wang; Wei Kang; Ka-Fai To; Jun Yu; Ho Ko; Le Yu; Sunny H. Wong; Tony Gin; Matthew Tak Vai Chan; Xiansong Wang; William Ka Kei Wu Cancer Res (2025) 85 (15): 2939–2952 Corrections(更正) 15 Correction: N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression 更正：N6甲基腺苷受体YTHDF1通过增强NOTCH1表达促进肝细胞癌的恶性和治疗耐药性 Xinyue Zhang; Tianhong Su; Yifan Wu; Yuhong Cai; Lina Wang; Cong Liang; Lei Zhou; Shiyan Wang; Xiao-Xing Li; Sui Peng; Ming Kuang; Jun Yu; Lixia Xu Cancer Res (2025) 85 (15): 2953 16 Correction: Inhibition of NF-κB-Dependent Signaling Enhances Sensitivity and Overcomes Resistance to BET Inhibition in Uveal Melanoma 更正：抑制NF-κB依赖的信号传导增强了葡萄膜黑色素瘤对BET抑制的敏感性并克服了抗性 Grazia Ambrosini; Catherine Do; Benjamin Tycko; Ronald B. Realubit; Charles Karan; Elgilda Musi; Richard D. Carvajal; Vivian Chua; Andrew E. Aplin; Gary K. Schwartz Cancer Res (2025) 85 (15): 2954 Cancer Res[Jour] AND 85[volume] AND 15_Supplement[issue] 癌症研究85卷 15期增刊 https://aacrjournals.org/cancerres/issue/ Abstracts: Frontiers in Cancer Science 2024; November 13-15, 2024; Singapore 摘要：《2024年癌症医学前沿》；2024年11月13日至15日；新加坡 LIGHTNING TALK ABSTRACTS（闪电演讲摘要） 1 Abstract LT01: Identifying Optimal Tumour-specific Promoters for CRISPR/Cas9 Engineering of Armoured CAR T Cells with Enhanced Safety and Efficacy 摘要LT01：鉴定用于增强安全性和有效性的装甲CAR - T细胞CRISPR/Cas9工程的最佳肿瘤特异性启动子 Kah Min Yap; Amanda X. Y. Chen ... Cancer Res (2025) 85 (15_Supplement): LT01 2 Abstract LT02: CRISPR-Cas9 as a Novel Cancer Gene Therapy Approach against Pancreatic Cancers 摘要LT02：CRISPR-Cas9作为一种新的癌症基因治疗胰腺癌的方法 Selina Shiqing K. Teh; Kirsten Bowland ... Cancer Res (2025) 85 (15_Supplement): LT02 3 Abstract LT03: Cell confinement by micropatterning induces phenotypic changes in cancer-associated fibroblasts 摘要LT03：微模式诱导的细胞隔离可诱导癌症相关成纤维细胞的表型改变 Aleksandr Mitriashkin; Josephine Yu Yan Yap ... Cancer Res (2025) 85 (15_Supplement): LT03 4 Abstract LT07: HEPATOCTYE-MACROPHAGE CROSSTALK VIA THE PGRN-EGFR AXIS MODULATES ADAR1-MEDIATED IMMUNITY IN THE LIVER 摘要LT07：通过PGRN-EGFR轴的肝-巨噬细胞交联调节肝脏中ADAR1介导的免疫 Wei Liang Gan; Xi Ren ... Cancer Res (2025) 85 (15_Supplement): LT07 5 Abstract LT08: Advancing Targeted Gene Therapy: Leveraging Dumbbell-Shaped DNA for Cell-Specific Precision in Cancer, Virus Infection and Mitochondrial Disease 摘要LT08：推进靶向基因治疗：利用哑铃形DNA在癌症、病毒感染和线粒体疾病中实现细胞特异性精确性 Pei She Loh (Rachel); Sushmita Poddar ... Cancer Res (2025) 85 (15_Supplement): LT08 6 Abstract LT10: Molecular mechanisms of SOCS1-mediated tumor suppression in prostate cancer 摘要LT10：SOCS1介导的前列腺癌症肿瘤抑制的分子机制 Awais Ullah Ihsan; Mozhdeh Namvarpour ... Cancer Res (2025) 85 (15_Supplement): LT10 POSTER PRESENTATION ABSTRACTS(海报展示摘要)（略） Cancer Res[Jour] AND 85[volume] AND 16[issue] 癌症研究 85卷 16期 https://aacrjournals.org/cancerres/issue/ In the Spotlightt(焦点) 1 A Spotlight on Oxidative Metabolism in Oncogenic Transformation and Cell Competition 氧化代谢在肿瘤转化和细胞竞争中的作用 Yogaspoorthi J. Subramaniam; Eugenia Piddini Cancer Res (2025) 85 (16): 2961–2962 In Focus(焦点) 2 Tumor–Immune Cell Interactions in Cancer Progression 癌症进展中的肿瘤-免疫细胞相互作用 Xiaoxue Zhou; Feng Xie; Long Zhang Cancer Res (2025) 85 (16): 2963–2966 Review(综述) 3 Informatics at the Frontier of Cancer Research 癌症研究前沿的信息学 Kathleen Noller; Taxiarchis Botsis; Pablo G. Camara; Lauren Ciotti; Lee A.D. Cooper; Jeremy Goecks; Malachi Griffith; Brian J. Haas; Trey Ideker; Rachel Karchin; Despina Kontos; Jiaying Lai; Daniel Marcus; Clifford A. Meyer; Kristen Naegle; Sarthak Pati; Bjoern Peters; Dexter Pratt; Benjamin J. Raphael; Michael Reich; Guergana K. Savova; Carrie Wright; Elana J. Fertig; Spyridon Bakas Cancer Res (2025) 85 (16): 2967–2986 Priority Report(优先报告) 4 SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition SMAD4缺乏促进胰腺癌进展并赋予TGFβ抑制的易感性 Gilbert Z. Murimwa; Natalie E. Williams; Dina Alzhanova; Amir Mohammadi; Jill M. Westcott; Francisca Beato; Ruifan Dai; Luis Nivelo; Francesca Rossi; Henry K. Fleming; Alexandra F. Tassielli; Zeynep Yazgan; Jason E. Toombs; Jason B. Fleming; Aatur D. Singhi; Cecilia G. Ethun; Huocong Huang; Rolf A. Brekken Cancer Res (2025) 85 (16): 2987–2996 Cancer Biology(癌症生物学) 5 SMARCA4 Loss Increases RNA Polymerase II Pausing and Elevates R-Loops to Inhibit BRCA1-Mediated Repair in Ovarian Cancer SMARCA4缺失会加剧RNA聚合酶II的转录暂停现象，并增加R环的形成，从而抑制卵巢癌中BRCA1介导的DNA损伤修复 Xianbing Zhu; Zheng Fu; Giulio Aceto; Jonathan St-Germain; Kexin Liu; Azadeh Arabzadeh; Yuxuan Qi; Yibo Xue; Leora Witkowski; Elise Graulich; Jutta Steinberger; Selim Misirlioglu; Nicklas Bassani; Racim Sansal; Amber Yasmeen; Geneviève Morin; Jingjie Guo; Anie Monast; Virginie Pilon; Alica Valachová; Kitty Pavlakis; Lili Fu; Walter H. Gotlieb; W. Glenn McCluggage; David Huntsman; Alexander J.R. Bishop; Douglas A. Levine; Morag Park; Yemin Wang; Brian Raught; William D. Foulkes; Sidong Huang Cancer Res (2025) 85 (16): 2997–3014 Cancer Immunology(癌症免疫学) 6 Reactivating cGAS–STING Signaling by Targeting SOS1 Enhances Antitumor Immunity in NRAS-Mutant Tumors 通过靶向 SOS1 重新激活 cGAS–STING信号传导在 NRAS突变肿瘤中增强抗肿瘤免疫力 Jia-Lu Shan; Kai-Ming Zhang; Wen-Qing Zhong; Xiao-Yu Yang; Zhi-Ling Li; Yun Huang; Tian Du; Dong Yang; Jia-Hong Tang; Yu-Hong Chen; Hai-Liang Zhang; Xiao-Feng Zhu; Rong Deng Cancer Res (2025) 85 (16): 3015–3031 Cancer Metabolism and Molecular Mechanisms(癌症代谢与分子机制) 7 Genome-Wide CRISPR Screening Reveals That mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer 全基因组CRISPR筛选揭示mTOR抑制在头颈癌中启动铁蛋白自噬和铁凋亡 Keiichi Koshizuka; Xingyu Wu; Kuniaki Sato; Pham Thuy Tien Vo; Gosia M. Murawska; Tomohiko Ishikawa; Zhiyong Wang; Alfredo A. Molinolo; Edward A. Dennis; Cherie-Ann O. Nathan; Prashant Mali; J. Silvio Gutkind Cancer Res (2025) 85 (16): 3032–3051 8 MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer MYLK-AS1 通过增强谷氨酰胺代谢促进 EGFR 抑制剂耐药性在非小细胞肺癌中的作用 Tianyu Qu; Lei Song; Jiali Xu; Xiyi Lu; Dandan Yin; Jiali Dai; Chen Zhang; Renhua Guo; Erbao Zhang Cancer Res (2025) 85 (16): 3052–3071 Translational Cancer Biology(转化癌症生物学) 9 CARM1-Mediated MAP2K4 Methylation Potentiates the Oncogenic Functions of MAP2K4 and Constitutes a Targetable Dependency in Triple-Negative Breast Cancer CARM1介导的MAP2K4甲基化增强MAP2K4的致癌功能，并在三阴性乳腺癌中构成可靶向的依赖性 Eui-Jun Kim; Yidan Wang; Yu-Lin Chen; Min Ma; Peng Liu; Megan S. Bacabac; Jingjing Zhou; Christopher J. Fry; Jordan R. Hoffman; Menggang Yu; Lingjun Li; Aussie Suzuki; Shulin Li; Wei Xu Cancer Res (2025) 85 (16): 3072–3088 10 Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma 开发一种抗CD99抗体使弥漫性中线胶质瘤能够被靶向治疗 Ilango Balakrishnan; Krishna Madhavan; Angela Pierce; Joshua Michlin; Breauna Brunt; Senthilnath Lakshmanachetty; Dong Wang; John DeSisto; Zachary James Nuss; Nathan Davidson; Faye Walker; Ammu Suresh; Andrew Donson; Bridget Sanford; Kenneth L. Jones; Etienne P. Danis; Siddhartha S. Mitra; Adam L. Green; Nathan Dahl; Rajeev Vibhakar; Sujatha Venkataraman Cancer Res (2025) 85 (16): 3089–3110 11 AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal Cancer AREG和EREG是胃食管癌对EGFR抑制反应的预测性生物标志物 Daniela Conticelli; Marco Volante; Filippo Pietrantonio; Claudia Orrù; Martina Olivero; Alessia Nottegar; Felice Borghi; Gian L. Baiocchi; Giovanni Crotti; Uberto Fumagalli Romario; Giovanni De Manzoni; Rossella Reddavid; Roberta Porporato; Dinçer Kılıç; Rebecca Ghione; Erika Calabrò; Russell Petty; Simona Corso; Silvia Giordano; Cristina Migliore Cancer Res (2025) 85 (16): 3111–3122 Cancer Landscapes（癌症特征） 12 Genomic Analyses Reveal the Evolving Characteristics of Intestinal Metaplasia and Gastric Cancer 基因组分析揭示肠化生和胃癌的进化特征 Xianfeng Xu; Caiwang Yan; Lijun Bian; Zhe Li; Yuhui Yu; Xia Zhu; Yun Gao; Hao Xu; Fengyuan Li; Yao Liu; Ping Sun; Zheng Wang; Yao Fu; Yue Jiang; Juncheng Dai; Hongxia Ma; Zhibin Hu; Hongbing Shen; Gang Li; Cheng Wang; Guangfu Jin Cancer Res (2025) 85 (16): 3123–3138 Convergence Science(融合医学) 13 Mathematical Modeling and Association Analysis Decipher the Impact of the Gut Microbiome on Cancer Immunotherapy 数学建模和关联分析解读肠道微生物组对癌症免疫治疗的影响 Andreas G. Hadjigeorgiou; Constantinos Harkos; Aditya K. Mishra; Golnaz Morad; Sarah B. Johnson; Nadim J. Ajami; Jennifer A. Wargo; Lance L. Munn; Triantafyllos Stylianopoulos; Rakesh K. Jain Cancer Res (2025) 85 (16): 3139–3155 14 Adaptation to Volumetric Compression Drives an Apoptosis-Resistant and Invasive Phenotype in Liver Cancer 适应体积压缩驱动肝癌细胞抗凋亡和侵袭性表型 Xiangyu Gong; Noriyoshi Ogino; M. Fátima Leite; Dingyao Zhang; Zehua Chen; Ryan Y. Nguyen; Raymond Liu; Emma Kruglov; Kaitlin Flores; Aidan T. Cabral; Gabriel Moreira de M. Mendes; Barbara E. Ehrlich; Michael Mak Cancer Res (2025) 85 (16): 3156–3175 Editor’s Notes(编辑注) 15 Editor’s Note: A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression 编辑注：一种靶向TRIP13的小分子抑制剂抑制多发性骨髓瘤进展 Yingcong Wang; Jing Huang; Bo Li; Han Xue; Guido Tricot; Liangning Hu; Zhijian Xu; Xiaoxiang Sun; Shuaikang Chang; Lu Gao; Yi Tao; Hongwei Xu; Yongsheng Xie; Wenqin Xiao; Dandan Yu; Yuanyuan Kong; Gege Chen; Xi Sun; Fulin Lian; Naixia Zhang; Xiaosong Wu; Zhiyong Mao; Fenghuang Zhan; Weiliang Zhu; Jumei Shi Cancer Res (2025) 85 (16): 3176 16 Editor’s Note: Cell Surface Tetraspanin Tspan8 Contributes to Molecular Pathways of Exosome-Induced Endothelial Cell Activation 编者注：细胞表面四跨膜蛋白Tspan8参与了外泌体诱导的内皮细胞活化的分子途径 Irina Nazarenko; Sanyukta Rana; Alexandra Baumann; Jessica McAlear; Andrea Hellwig; Michael Trendelenburg; Günter Lochnit; Klaus T. Preissner; Margot Zöller Cancer Res (2025) 85 (16): 3177 Cancer Res[Jour] AND 85[volume] AND 17[issue] 癌症研究 85卷 17期 https://aacrjournals.org/cancerres/issue/ Obituary（讣告） 1 Eva Klein, MD, PhD, FAACR: In Memoriam (1925–2025) 伊娃·克莱因（Eva Klein）医学博士、哲学博士、美国癌症研究学会会士：缅怀（1925-2025） Maria Teresa Bejarano; Marie Arsenian Henriksson Cancer Res (2025) 85 (17): 3185. In the Spotlight（亮点） 2 Another Slice of the Pie Uncovered: RIT1M90I Is an Actionable Driver in Non–Small Cell Lung Cancer 又一块“蛋糕”被揭开：RIT1M90I是非小细胞肺癌中的可干预驱动因素 Cheng Pei Wu; Aria Vaishnavi Cancer Res (2025) 85 (17): 3186–3188. 3 Bone Voyage: OPN's Path from Skeleton to Systemic Immunosuppression 骨之旅：骨桥蛋白（OPN）从骨骼到全身免疫抑制的路径 Kyoko Hashimoto; Kazuo Okamoto; Hiroshi Takayanagi Cancer Res (2025) 85 (17): 3189–3191. In Focus（聚焦） 4 Lactylation in Cancer: Advances, Challenges, and Future Perspectives 癌症中的乳酸化：进展、挑战与未来展望 Zhi Zong; Long Zhang; Fangfang Zhou Cancer Res (2025) 85 (17): 3192–3195. Priority Report（重点研究简报） 5 RIT1 Drives Oncogenic Transformation and Is an Actionable Target in Lung Adenocarcinoma RIT1驱动肺腺癌的致癌性转化，是可干预的靶点 Alessandro M. Mozzarelli; Antonio Cuevas-Navarro; Emily G. Shuldiner; Martha Vega; Walid K. Chatila; Jierui Xu; Henry S. Walch; Yuzhe Niu; Dmitri A. Petrov; Nikolaus Schultz; Anatoly Urisman; Charles M. Rudin; Monte M. Winslow; Pau Castel Cancer Res (2025) 85 (17): 3196–3206. Cancer Biology（癌症生物学） 6 RIT1M90I Is a Driver of Lung Adenocarcinoma Tumorigenesis and Resistance to Targeted Therapy RIT1M90I是肺腺癌发生和靶向治疗耐药的驱动因素 Ashley V. DiMarco; Mirunalini Ravichandran; Jeff Lau; Anthony Lima; Jennifer Lacap; Pablo Saenz-Lopez Larrocha; Eva Lin; Julie Weng; Luca Gerosa; Thomas Hunsaker; Yang Xiao; Monika Miś; Charles Havnar; Wennie Chen; Kai H. Barck; Klara Totpal; Oded Foreman; Nicole M. Sodir; Mark Merchant; Danilo Maddalo Cancer Res (2025) 85 (17): 3207–3218. 7 XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance XPO1R749Q突变与癌症中的POLE突变共存，可成为克服化疗耐药性的靶点 Tulasigeri M. Totiger; Wannasiri Chiraphapphaiboon; Yasmine Baca; Sana Chaudhry; Ryan Q. Notti; Skye Montoya; Monika Chojnacka; Gabriel Gaidosh; Jumana Afaghani; Maurizio Affer; Christopher Armstrong; Paul M. Kavanaugh; Efe Karaca; Jenna Zabroski; Michael Lewis; Alyssa Maye; Jacob Jahn; Rajesh K. Soni; Daniel Bilbao; Phil Walker; Andrew Elliott; Emil Lou; Wafik S. El-Deiry; Jose Antonio Rodriguez; Hai Dang Nguyen; Justin Taylor Cancer Res (2025) 85 (17): 3219–3233. 8 The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2 C端激酶结构域结合与抑制基序可防止成纤维细胞生长因子受体2（FGFR2）的组成性激活 Daniel Zingg; Chi-Chuan Lin; Julia Yemelyanenko; Lukasz Wieteska; Sjors M. Kas; Onno B. Bleijerveld; Xue Chao; Jinhyuk Bhin; Catrin Lutz; Ellen Wientjens; Sjoerd Klarenbeek; Giulia Zanetti; Stefano Annunziato; Bjørn Siteur; Eline van der Burg; Anne Paulien Drenth; Marieke van de Ven; Lodewyk F.A. Wessels; Maarten Altelaar; John E. Ladbury; Jos Jonkers Cancer Res (2025) 85 (17): 3234–3257. Cancer Immunology（癌症免疫学） 9 Tumor-Specific MHC-II Activates CD4+ and CD8+ T Cells in Head and Neck Squamous Cell Carcinoma to Boost Immunotherapy Efficacy 头颈部鳞状细胞癌中肿瘤特异性主要组织相容性复合体II类分子（MHC-II）激活CD4+和CD8+T细胞，增强免疫治疗疗效 Yuying Zhang; Jinbang Li; Xiaoyu Guo; Zhao Gao; Junchen Pan; Sheng Nong; Jiyuan Ma; Gang Chen; Jiali Zhang Cancer Res (2025) 85 (17): 3258–3274. Cancer Metabolism and Molecular Mechanisms（癌症代谢与分子机制） 10 PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer 过氧化物酶体增殖物激活受体δ（PPARδ）协调胰腺癌对微环境信号的促转移代谢反应 Beatriz Parejo-Alonso; David Barneda; Sara Maria David Trabulo; Sarah Courtois; Sara Compte-Sancerni; Jelena Zurkovic; Laura Ruiz-Cañas; Quan Zheng; Jiajia Tang; Matthias M. Gaida; Ulf Schmitz; Pilar Irun; Laure Penin-Peyta; Shanthini Mary Crusz; Petra Jagušt; Pilar Espiau-Romera; Alba Royo-García; Andrés Gordo-Ortiz; Mariia Yuneva; Meng-Lay Lin; Shenghui Huang; Ming-Hsin Yang; Angel Lanas; Bruno Sainz, Jr; Christoph Thiele; Christopher Heeschen; Patricia Sancho Cancer Res (2025) 85 (17): 3275–3291. 11 TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis TRAF3IP2-AS1缺乏诱导坏死性凋亡，促进胰腺癌肝转移 Yong-Ding Wu; Xiao-Xiao Huang; Hao-Xiang Zhang; Yu Pan; Cheng-Ke Xie; Ge Li; Cai-Feng Lin; Xin-Quan Lin; Zhi-Yuan Li; Yin-Hao Chen; Jian-Fei Hu; Hong-Yi Lin; Shun-Cang Zhu; Zu-Wei Wang; Yi-Feng Tian; Qiao-Wei Li; Cheng-Yu Liao; Shi Chen Cancer Res (2025) 85 (17): 3292–3312. 12 Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression 神经酰胺诱导的代谢应激耗竭延胡索酸，驱动线粒体自噬以介导肿瘤抑制 Natalia V. Oleinik; Firdevs Cansu Atilgan; Mohamed Faisal Kassir; Han Gyul Lee; Alhaji H. Janneh; Wyatt Wofford; Chase Walton; Zdzislaw M. Szulc; Elizabeth G. Hill; Alexander V. Alekseyenko; Huseyin Cimen; Jessica H. Hartman; Christina Voelkel-Johnson; Michael B. Lilly; John J. Lemasters; Norma Frizzell; Xue-Zhong Yu; Shikhar Mehrotra; Besim Ogretmen Cancer Res (2025) 85 (17): 3313–3334. Translational Cancer Biology（癌症转化生物学） 13 Dietary Fiber Lacks a Consistent Effect on Immune Checkpoint Blockade Efficacy Across Diverse Murine Tumor Models 在不同的小鼠肿瘤模型中，膳食纤维对免疫检查点阻断疗效的影响不一致 Asael Roichman; Gabriela Reyes-Castellanos; Ziqing Chen; Zihong Chen; Sarah J. Mitchell; Michael R. MacArthur; Akshada Sawant; Llewelyn Levett; Jesse R. Powers; Victoria Burgo; Maria Gomez-Jenkins; Maria Ibrahim; Xincheng Xu; Beianka Tomlinson; Xiang Hang; Eric G. Pamer; Yong Wei; Yibin Kang; Eileen P. White; Joshua D. Rabinowitz Cancer Res (2025) 85 (17): 3335–3347. 14 NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma 神经纤维蛋白1（NF1）缺失促进表皮生长因子受体（EGFR）激活，使NF1突变型黑色素瘤对EGFR抑制敏感 Milad Ibrahim; Irineu Illa-Bochaca; George Jour; Eleazar Vega-Saenz de Miera; Joseph Fracasso; Kelly Ruggles; Iman Osman; Markus Schober Cancer Res (2025) 85 (17): 3348–3364. Cancer Res[Jour] AND 85[volume] AND 18[issue] 癌症研究 85卷 18期 https://aacrjournals.org/cancerres/issue/ In the Spotlight（聚焦） 1 A New VISTA in Intracellular Checkpoint Signaling in Triple-Negative Breast Cancer 三阴性乳腺癌细胞内检查点信号传导的新“VISTA” Jacqueline J. Tao; Neil Vasan Cancer Res (2025) 85 (18): 3371–3372. 2 The Approaching Darwinian Era in Oncology 肿瘤学中达尔文时代的来临 Robert A. Gatenby Cancer Res (2025) 85 (18): 3373–3375. 3 Catch Me If You Can: Could Y Chromosome Loss Spread in Cancer? 想抓我？没那么容易：Y染色体缺失会在癌症中传播吗？ Zihai Li Cancer Res (2025) 85 (18): 3376–3377. Review（综述） 4 Plasticity and Functional Heterogeneity of Cancer-Associated Fibroblasts 癌症相关成纤维细胞的可塑性与功能异质性 Jacqueline M. Flynn; Nikita Thadani; Erin E. Gallagher; Isabella Azzaro; Cameron M. Bodnar; Colin P. McCarty; Gabriele Romano; Marie R. Webster; Claudia Capparelli Cancer Res (2025) 85 (18): 3378–3398. Cancer Biology（癌症生物学） 5 A Four Amino Acid Intracellular Motif of VISTA Blocks Growth Receptor Signaling in Cancer Cells to Induce Tumor Suppression VISTA的四个氨基酸细胞内基序可阻断癌细胞中的生长受体信号传导以诱导肿瘤抑制 Yan Zhao; Tina Andoh; Fatima Charles; Priyanka Reddy; Kristina Paul; Harsh Goar; Ishrat Durdana; Caiden J. Golder; Ashley N. Hardy; Marisa M. Juntilla; Soo-Ryum Yang; Chien-Yu Lin; Idit Sagiv-Barfi; Benjamin S. Geller; Stephen Moore; Dipti Thakkar; Jerome D. Boyd-Kirkup; Yan Peng; James M. Ford; Melinda L. Telli; Song Zhang; Allison W. Kurian; Robert B. West; Tao Yue; Andrew M. Lipchik; Michael P. Snyder; Joshua J. Gruber Cancer Res (2025) 85 (18): 3399–3415. 6 Mitochondrial Calcium Uniporter Links Acetyl-CoA Metabolism and H3K27 Acetylation to Maintain Glioblastoma Stem Cells 线粒体钙单向转运体将乙酰辅酶A代谢和H3K27乙酰化联系起来以维持胶质母细胞瘤干细胞 Guangqin Liu; Haoqian Zhang; Siqi Chen; Jun Gao; Haixin Zhao; Yan Dong; Changwei Liu; Xuechen Wei; Ting Li; Chang Lu; Haizhen Zhu; Dingyi Lu; Shiyu Feng; Teng Li; Weina Zhang; Qing Xia; Jianghong Man; Tao Zhou; Jiayi Chen; Ailing Li; Xin Pan Cancer Res (2025) 85 (18): 3416–3434. Cancer Immunology（癌症免疫学） 7 Prostate Cancer Cells Secrete PD-1 in Exosomes to Enhance Myeloid-Derived Suppressor Cell Activity and Promote Tumor Immune Evasion 前列腺癌细胞在外泌体中分泌PD-1以增强髓源性抑制细胞活性并促进肿瘤免疫逃逸 Jie Zhang; Weiwu Chen; Chen Zhang; Qian He; Xudong Wang; Jiayu Han; Peng Gao; Kunyu Wang; Haoze Xie; Feng Gao; Yining Guo; Wenhao Guo; Haofei Jiang; Jing Le; Ruichen Zang; Sisi Mo; Haobo Fan; Xiaoxiao Zhu; Xinrong Jiang; Fengbin Gao; Yanlan Yu; Guoqing Ding; Yicheng Chen Cancer Res (2025) 85 (18): 3435–3453. 8 FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors 肝细胞癌中FADD的激活可增强CD8+ T细胞反应并增强对免疫检查点抑制剂的敏感性 Jiahuan Lu; Thomas Ting-Hei Chan; Yun Wang; Jingya Wang; Zhewen Xiong; Jingqing Li; Yixuan Zhang; Huanyu Wang; Jintian Chen; Weiqin Yang; Jing Wang; Yalin Tu; Howard H.W. Leung; Raymond Wai Ming Lung; Wei Kang; Man Tong; Dan Michelle Wang; Qi-Nian Wu; Zhao-Lei Zeng; Alfred Sze-Lok Cheng; Ka-Fai To; Anthony W.H. Chan; Jingying Zhou Cancer Res (2025) 85 (18): 3454–3470. Cancer Metabolism and Molecular Mechanisms（癌症代谢与分子机制） 9 Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer 选择性利用丙氨酸转运体是ARID1A突变型卵巢癌的治疗弱点 Hao Nie; Liping Liao; Rafal J. Zielinski; Javier A. Gomez; Akshay V. Basi; Erin H. Seeley; Lin Tan; Agnes Julia Bilecz; Wei Zhou; Heng Liu; Chen Wang; Shuai Wu; Yuan Qi; Taito Miyamoto; Federica Severi; Aaron R. Goldman; Shengqing Gu; Anil K. Sood; Amir A. Jazaeri; Ronny Drapkin; Daniel T. Claiborne; Nan Zhang; Philip L. Lorenzi; Jared K. Burks; Ernst Lengyel; Eyal Gottlieb; Rugang Zhang Cancer Res (2025) 85 (18): 3471–3489. Therapeutic Development and Chemical Biology（治疗开发与生物化学） 10 A Peptide-Based PROTAC Degrader of BRCA2 Sensitizes Metastatic Castration-Resistant Prostate Cancer to PARP Inhibition 一种基于肽的BRCA2 PROTAC降解剂可使转移性去势抵抗性前列腺癌对PARP抑制剂敏感 Qi Ye; Bohan Ma; Lei Li; Zixi Wang; Mingming Lu; Jialu Kang; Yuzeshi Lei; Shan Xu; Ke Wang; Yanlin Jian; Yizeng Fan; Bin Wang; Jing Liu; Yang Gao; Jian Ma; Lei Li Cancer Res (2025) 85 (18): 3490–3502. Translational Cancer Biology（癌症转化生物学） 11 Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control 适应性治疗利用化疗耐药性卵巢癌的适应性缺陷实现长期肿瘤控制 Helen Hockings; Eszter Lakatos; Weini Huang; Maximilian Mossner; Mohammed A. Khan; Nikolina Bakali; Jacqueline McDermott; Kane Smith; Ann‐Marie Baker; Trevor A. Graham; Michelle Lockley Cancer Res (2025) 85 (18): 3503–3517. 12 CRISPR–Drug Combinatorial Screening Identifies Effective Combination Treatments for MTAP-Deleted Cancer CRISPR-药物组合筛选确定了针对MTAP缺失型癌症的有效联合治疗方案 Nikola Knoll; Sarah Masser; Blanka Bordas; Richard Y. Ebright; Guangyan Li; Devishi Kesar; Eliana Destefanis; Nicholas Kania; Diego J. Rodriguez; Jayu Jen; Sydney E. Zagar; Caleb Mensah; Zixin Chen; Samuel J. Moffitt; Erhumuoghene M. Enakireru; Yao He; Baomou Feng; Mira K. Chokshi; Cyrus Y. Jin; Srivatsan Raghavan; William R. Sellers; Kathleen M. Mulvaney Cancer Res (2025) 85 (18): 3518–3539. 13 Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer MTA协同PRMT5抑制剂BMS-986504与KRAS抑制剂联合是治疗MTAP缺失型KRAS突变胰腺癌的有效治疗策略 Kristina Drizyte-Miller; Lars D. Engstrom; Jeffrey A. Klomp; Clint A. Stalnecker; Addison G. Stamey; Khalilah E. Taylor; Mallory K. Roach; Ryan Robb; Laura M. Waters; Andrew Calinisan; Seamus Degan; Wen-Hsuan Chang; Xousaen M. Helu; David Nguyen; Elisa Baldelli; Mariaelena Pierobon; Emanuel F. Petricoin; David M. Briere; Jill Hallin; James G. Christensen; Kirsten L. Bryant; Adrienne D. Cox; Peter Olson; Channing J. Der Cancer Res (2025) 85 (18): 3540–3557. Cancer Landscapes（癌症特征） 14 Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy–Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response 对新辅助化疗治疗前后的卵巢癌进行多组学分析揭示了肿瘤发生和化疗反应的介导因子 Mark C. Valentine; Mary M. Mullen; Emilee N. Kotnik; Matthew A. Powell; Premal H. Thaker; Carolyn K. McCourt; Lindsay M. Kuroki; Andrea R. Hagemann; Rebecca C. Arend; Alex S. Holehouse; Robi Mitra; David G. Mutch; Katherine C. Fuh Cancer Res (2025) 85 (18): 3558–3570. Editor’s Note（编者按） 15 Editor’s Note: Nuclear-Cytoplasmic Partitioning of Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN) Differentially Regulates the Cell Cycle and Apoptosis 编者按：第10号染色体缺失的磷酸酶和张力蛋白同源物（PTEN）的核质分布差异调控细胞周期和细胞凋亡 Ji-Hyun Chung; Charis Eng Cancer Res (2025) 85 (18): 3571. Retraction（撤稿声明） 16 Retraction: Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN) Has Nuclear Localization Signal-Like Sequences for Nuclear Import Mediated by Major Vault Protein 撤稿声明：第10号染色体缺失的磷酸酶和张力蛋白同源物（PTEN）具有由主要穹窿蛋白介导的核定位信号样序列以实现核输入 Ji-Hyun Chung; Margaret E. Ginn-Pease; Charis Eng Cancer Res (2025) 85 (18): 3572. Cancer Res[Jour] AND 85[volume] AND 18_Supplement[issue] 癌症研究 85卷 18期增刊 https://aacrjournals.org/cancerres/issue/85/18_Supplement Abstracts: AACR Special Conference in Cancer Research: Advances in Ovarian Cancer Research; September 19-21, 2025; Denver, CO 摘要：美国癌症研究协会（AACR）癌症研究特别会议：卵巢癌研究进展；2025年9月19 - 21日；美国科罗拉多州丹佛市 GENOMICS 基因组学 KEYNOTE LECTURE 主题演讲 PATHOLOGY 病理学 PATIENT ADVOCACY: CLINICAL TRIALS AND SURVIVORSHIP 患者权益倡导：临床试验与生存者关怀 PRECISION THERAPY 精准治疗 TUMOR HETEROGENEITY 肿瘤异质性 TUMOR IMMUNOLOGY 肿瘤免疫学 TUMOR IMMUNOLOGY (BIOLOGY) 肿瘤免疫学（生物学方向） TUMOR INITIATION 肿瘤发生起始 OTHER TOPICS 其他主题 Cancer Res[Jour] AND 85[volume] AND 18_Supplement_2[issue] 癌症研究 85卷 18期增刊2期 https://aacrjournals.org/cancerres/issue/85/18_Supplement_2 Abstracts: AACR Special Conference in Cancer Research: Discovery and Innovation in Pediatric Cancer—From Biology to Breakthrough Therapies; September 25-28, 2025; Boston, MA 摘要：美国癌症研究协会（AACR）癌症研究特别会议：儿童癌症领域的发现与创新——从生物学研究到突破性疗法；2025年9月25 - 28日；美国马萨诸塞州波士顿市 BIOMARKERS AND INTEGRATION OF MOLECULAR APPROACHES INTO DIAGNOSTICS 生物标志物及分子方法在诊断中的应用整合 CANCER BIOLOGY, TUMOR HETEROGENEITY, EARLY DETECTION AND CTDNA 癌症生物学、肿瘤异质性、早期检测与循环肿瘤DNA（ctDNA） CLINICAL TRIALS 临床试验 DEVELOPMENT IN CANCER AND CANCER EPIGENETICS 癌症发生发展及癌症表观遗传学研究 DISCOVERY AND TRANSLATION OF TARGETS 靶点发现与转化应用 IMMUNOLOGY AND IMMUNO-ONCOLOGY IN CHILDHOOD CANCERS 儿童癌症的免疫学与免疫肿瘤学 MECHANISMS UNDERLYING CHILDHOOD CANCER 儿童癌症的潜在发生机制 OTHER TOPICS 其他主题 Cancer Res[Jour] AND 85[volume] AND 18_Supplement_3[issue] 癌症研究 85卷 18期增刊3期 https://aacrjournals.org/cancerres/issue/85/18_Supplement_3 Abstracts: AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research—Emerging Science Driving Transformative Solutions; September 28 - October 1, 2025; Boston, MA 摘要：美国癌症研究协会（AACR）癌症研究特别会议：胰腺癌研究进展——新兴科学推动变革性解决方案；2025年9月28日 - 10月1日；马萨诸塞州波士顿市 BIOLOGY OF PANCREATIC CANCER PROGRESSION 胰腺癌进展生物学 CLINICAL TRIALS (INCLUDING TRIALS IN PROGRESS) 临床试验（含进行中的试验） HARNESSING THE IMMUNE SYSTEM TO TREAT PANCREATIC CANCER 利用免疫系统治疗胰腺癌 NEW THERAPEUTIC STRATEGIES 新型治疗策略 REVOLUTIONIZING EARLY DIAGNOSIS AND PREVENTION 革新早期诊断与预防手段 SPOTLIGHT ON NEW DRUG DEVELOPMENT 聚焦新药研发 TRANSLATIONAL ADVANCES TO DISSECT PANCREATIC CANCER TREATMENT RESPONSE 转化研究进展：解析胰腺癌治疗反应 TUMOR HETEROGENEITY AND EVOLUTION 肿瘤异质性与演进 OTHER TOPICS 其他主题 Cancer Res[Jour] AND 85[volume] AND 19[issue] 癌症研究 85卷 19期 https://aacrjournals.org/cancerres/issue/ In the Spotlight（焦点） 1 Ceramide Links Alzheimer’s Disease to Decreased Cancer Risk: A Lipid Behind the Enigma of Inverse Comorbidity 神经酰胺：连接阿尔茨海默病与癌症风险降低的纽带——逆共病现象背后的脂质奥秘 Erhard Bieberich Cancer Res (2025) 85 (19): 3579–3581. 2 Generations in Flux: Tracking the Birth of Cellular Heterogeneity in Cancer 代际更迭：追踪癌症细胞异质性的起源 Aaron McKenna Cancer Res (2025) 85 (19): 3582–3583. Review（综述） 3 Challenges and Opportunities in Analyzing Cancer-Associated Microbiomes 分析癌症相关微生物组的挑战与机遇 Minghao Chia; Mihai Pop; Steven L. Salzberg; Niranjan Nagarajan Cancer Res (2025) 85 (19): 3584–3595. Resource Report（资源报告） 4 Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells 泛癌症分析完善肿瘤浸润树突状细胞的单细胞图谱 Tianyi Ma; Xiaojing Chu; Jinyu Wang; Xiangjie Li; Yu Zhang; Dan Tong; Wenbin Xu; Guohui Dang; Lu Qi; Yuhui Miao; Zemin Zhang; Sijin Cheng Cancer Res (2025) 85 (19): 3596–3613. Cancer Biology（癌症生物学） 5 Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T Cells SOX10缺陷型黑色素瘤中转谷氨酰胺酶-2升高促进肿瘤发生并减少肿瘤内CD4+ T细胞 Signe Caksa; Timothy J. Purwin; Dan A. Erkes; Kristen M. DeRosa; Erica Kitterman; Samantha M. Barnada; Casey D. Stefanski; Haley P. Wilson; Glenn L. Mersky; McKenna Q. Glasheen; Jacob S. Heilizer; Namra Ajmal; Yunguang Sun; Joanna S.Y. Chan; Hallgeir Rui; Inna Chervoneva; Claudia Capparelli; Andrew E. Aplin Cancer Res (2025) 85 (19): 3614–3632. 6 Tumor-Derived CCL16 Normalizes Tumor Vasculature through Macrophage ICAM-1 Receptor and Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma 肿瘤来源的CCL16通过巨噬细胞ICAM-1受体使肿瘤血管正常化并增强肝细胞癌免疫治疗疗效 Kunling Chen; Huolun Feng; Yujie Zhang; Jingyuan Pei; Yuyan Xu; Xiangxu Wei; Zhuohao Chen; Zhoubin Feng; Lei Cai; Yong Li; Liang Zhao; Mingxin Pan Cancer Res (2025) 85 (19): 3633–3650. Cancer Metabolism and Molecular Mechanisms（癌症代谢与分子机制） 7 BBOX1 Is a Metabolic Checkpoint That Mediates Metastatic Cancer Cell Evasion from Immunosurveillance by NK Cells BBOX1是代谢检查点，介导转移性癌细胞逃逸自然杀伤（NK）细胞的免疫监视 Chuanjie Zhang; Hongchao He; Yi Gao; Jiawei Ding; Hai Huang; Yixun Liu; Hanqing Liu; Jun Xiao; Dan-feng Xu; Zunguo Du; Zhenbo Zhang; Lechi Ye Cancer Res (2025) 85 (19): 3651–3670. 8 Hypoxia-Induced Creatine Uptake Reprograms Metabolism to Antagonize PARP1-Mediated Cell Death and Facilitate Tumor Progression in Hepatocellular Carcinoma 缺氧诱导的肌酸摄取重编程代谢，对抗PARP1介导的细胞死亡并促进肝细胞癌进展 Rui-Zhe Li; Guo-Qiang Pan; Chen Xiong; Zi-Niu Ding; Tuan-Song Zhang; Lun-Jie Yan; Dongxu Wang; Xiaolu Zhang; Xiao-Feng Dong; Yu-Chuan Yan; Yu Zhou; Rui Dong; Zhao-Ru Dong; Tao Li Cancer Res (2025) 85 (19): 3671–3688. 9 TERC Stimulates Fatty Acid Metabolism to Promote Bladder Cancer Progression TERC刺激脂肪酸代谢以促进膀胱癌进展 Chen Chen; Yuting Gao; Renquan Lu; Ying Wu; Yiwen Yao; Ruixin Sun; Junlu Wu; Ping Ji; Wenqiang Quan; Denglong Wu; Zujun Sun; Dong Li Cancer Res (2025) 85 (19): 3689–3705. Therapeutic Development and Chemical Biology（治疗开发与生物化学） 10 Lipid Nanoparticle–Encapsulated mRNAs Encoding Tumor-Specific Toxin Proteins Selectively Target Cancer Cells and Stimulate T-cell Infiltration 脂质纳米颗粒包裹的编码肿瘤特异性毒素蛋白的mRNA选择性靶向癌细胞并刺激T细胞浸润 Rui Zhou; Lu Han; Jing Wang; Ling Ma; Tingting Zhang; Tianming Qi; Meichen Liu; Yijie Dong; Weiguo Zhang; Shan Cen Cancer Res (2025) 85 (19): 3706–3716. Translational Cancer Biology（癌症转化生物学） 11 Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes Lymphoma Cells to Ferroptosis and CAR T-cell Immunotherapy 通过抑制帽子依赖性起始来阻断NRF2翻译，使淋巴瘤细胞对铁死亡和嵌合抗原受体（CAR）T细胞免疫治疗敏感 Paola Manara; Austin D. Newsam; Venu Venkatarame Gowda Saralamma; Tyler Andrew Cunningham; Drew Lazenby; J.J.David Ho; Marco Vincenzo Russo; Abdessamad Youssfi Alaoui; Dhanvantri Chahar; Alicia Bilbao Martinez; Nikolai Fattakhov; Alexandra Marie Carbone; Olivia Barbara Farag; Alexa Marie Barroso; Kyle Hoffman; Francesco Maura; Daniel Bilbao; Jonathan H. Schatz Cancer Res (2025) 85 (19): 3717–3736. 12 Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy 碳酸酐酶抑制使3组髓母细胞瘤对放疗敏感 Cory M. Richman; Alexandra Rasnitsyn; Borja L. Holgado; Maria Vladoiu; Namal Abeysundara; Sandra Majo; Sara Chabi; Lucie J. Taunay; Hiromichi Suzuki; Ichiyo Shibahara; Joonas Haapasalo; Jonelle G. Pallotta; Tajana Douglas; Kaitlin Kharas; Kyle Juraschka; Oliver Ocsenas; Sachin A. Kumar; Kristiina Nordfors; Ana Guerreiro Stücklin; Raul A. Suarez; Jiao Zhang; Xiaochong Wu; Craig Daniels; Livia Garzia; Jüri Reimand; Olivier Saulnier; Thomas E. Merchant; Celio Pouponnot; David R. Raleigh; Michael D. Taylor; Pasqualino De Antonellis Cancer Res (2025) 85 (19): 3737–3751. 13 Oxytocin Receptor Regulates the Hippo/YAP Axis to Drive Hepatocarcinogenesis 催产素受体调控Hippo/YAP轴以驱动肝细胞癌发生 Huijie Yang; Jiayao Cui; Peng Su; Xiujie Cui; Haojie Guo; Penghe Yang; Shuqing Zhang; Chenmiao Zhang; Mingxi Fu; Zhongbo Li; Yinlu Ding; Ting Zhuang; Jian Zhu; Xiaodong Tan Cancer Res (2025) 85 (19): 3752–3770. Cancer Landscapes（癌症特征） 14 Integrated Omics and Multicohort Analyses Identify an Enhancer Variant Linking Ferroptosis to Precision Therapy in Prostate Cancer 整合组学和多队列分析确定一个增强子变异，将铁死亡与前列腺癌精准治疗联系起来 Sheng Ma; Yue Ge; Zequn Lu; Junbiao Zhang; Qin Zhang; Yuzheng Peng; Zirui Xi; Hao Peng; Meng-Yao Xu; Zezhong Xiong; Yuan Gao; Yanan Wang; Le Li; Chunyu Zhang; Zheng Chao; Tengfei Li; Ruiyun Zhang; Qiang Zhang; David A. Horne; Baojun Wang; Xu Gao; Xu Zhang; Jianbo Tian; Jing Li; Meng Jin; Gong-Hong Wei; Zhihua Wang Cancer Res (2025) 85 (19): 3771–3790. Convergence Science（互动医学） 15 Alzheimer's Disease–Associated Amyloid-βPrecursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity 阿尔茨海默病相关淀粉样蛋白-β前体蛋白可防止衰老应激诱导的线粒体自噬和富马酸盐耗竭，从而改善抗肿瘤免疫 Mohamed Faisal Kassir; Han Gyul Lee; Natalia V. Oleinik; Wyatt Wofford; Chase Walton; Firdevs Cansu Atilgan; Alhaji H. Janneh; Paramita Chakraborty; Kubra Calisir; Elif Percin; Silvia G. Vaena; Kalyani Sonawane; Ashish Deshmukh; Narayan R. Bhat; Kumar Sambamurti; Onder Albayram; Ozgur Sahin; Shikhar Mehrotra; Besim Ogretmen Cancer Res (2025) 85 (19): 3791–3811. Editor’s Notes（编者按） 16 Editor’s Note: A Novel L-Asparaginase with low L-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo 编者按：一种低L-谷氨酰胺酶共活性的新型L-天冬酰胺酶对体内T细胞和B细胞急性淋巴细胞白血病均具有高效治疗作用 Hien Anh Nguyen; Ying Su; Jenny Y. Zhang; Aleksandar Antanasijevic; Michael Caffrey; Amanda M. Schalk; Li Liu; Damiano Rondelli; Annie Oh; Dolores L. Mahmud; Maarten C. Bosland; Andre Kajdacsy-Balla; Sofie Peirs; Tim Lammens; Veerle Mondelaers; Barbara De Moerloose; Steven Goossens; Michael J. Schlicht; Kasim K. Kabirov; Alexander V. Lyubimov; Bradley J. Merrill; Yogen Sauntharajah; Pieter Van Vlierberghe; Arnon Lavie Cancer Res (2025) 85 (19): 3812. 17 Editor’s Note: Werner Syndrome Helicase Has a Critical Role in DNA Damage Responses in the Absence of a Functional Fanconi Anemia Pathway 编者按：沃纳综合征解旋酶在无功能性范可尼贫血通路时对DNA损伤反应起关键作用 Monika Aggarwal; Taraswi Banerjee; Joshua A. Sommers; Chiara Iannascoli; Pietro Pichierri; Robert H. Shoemaker; Robert M. Brosh, Jr. Cancer Res (2025) 85 (19): 3813. Cancer Res[Jour] AND 85[volume] AND 20[issue] 癌症研究 85卷 20期 https://aacrjournals.org/cancerres/issue/ In the Spotlight（聚焦热点） 1 Precision Epigenetic Reprogramming: CoREST Inhibition Sensitizes STK11-Mutant Tumors to Immune Checkpoint Blockade Therapy 精准表观遗传重编码：抑制CoREST使STK11突变肿瘤对免疫检查点阻断疗法敏感 De-Chen Lin; Keyue Shen Cancer Res (2025) 85 (20): 3821–3822. 2 From Harmony to Discord: Multicellular Coordination in Tissues and Its Rewiring in Cancer 从和谐到失调：组织中多细胞协调及其在癌症中的重编码 Merve Dede; Vakul Mohanty; Ken Chen Cancer Res (2025) 85 (20): 3823–3825. Review（综述） 3 P2 Purinergic Receptors in Tumor Immunity 肿瘤免疫中的P2嘌呤能受体 Xin Wang; Shu-Heng Jiang; Mingyue Ma; Shuqi Cai; Dong Song; Bing Han Cancer Res (2025) 85 (20): 3826–3841. Priority Report（优先报道） 4 Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression PROX1的表观遗传去抑制促进神经内分泌前列腺癌进展 Varadha Balaji Venkadakrishnan; Adam Presser; Nathaniel C.E. Voss; James Neiswender; Lisa Brenan; Keira Prenza Sosa; Kenny Weng; Andres M. Acosta; Francisca Vazquez; Himisha Beltran Cancer Res (2025) 85 (20): 3842–3854. Resource Report（资源报道） 5 Genetic Control of tRNA-Derived Fragments Contributes to Cancer Risk tRNA衍生片段的遗传调控对癌症风险的影响 Bin Li; Hanting Li; Yan Li; Zhirui Chen; Danyi Zou; Chunyi He; Songqiang Li; Kexin Hu; Caibo Ning; Yanmin Li; Hui Geng; Shuhui Yang; Chaoqun Huang; Xiaojun Yang; Qiuhong Wang; Xu Zhu; Xiangpan Li; Ying Zhu; Meng Jin; Xiaoping Miao; Jianbo Tian Cancer Res (2025) 85 (20): 3855–3874. Cancer Biology（癌症生物学） 6 HPV E5 Mediates Resistance to Chemotherapy and Radiation by Promoting a Stem Cell–Like Phenotype in Head and Neck Squamous Cell Carcinoma HPV E5通过促进头颈部鳞状细胞癌的干细胞样表型，介导对化疗和放疗的耐药性 Souvick Roy; Sayuri Miyauchi; Riley N. Jones; Sangwoo S. Kim; Aldo Venuti; Angad S. Boparai; Loren K. Mell; Theresa Guo; Joseph A. Califano; Andrew B. Sharabi Cancer Res (2025) 85 (20): 3875–3893. 7 SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification SRSF9形成相分离凝聚物，通过诱导RNA选择性剪接促进卵巢癌进展，而该过程受m6A修饰抑制 Xinzhao Zuo; Jie Xu; Dan Yang; Chenyue Yang; Xiaoyi Liu; Ningxuan Chen; Haocheng Wang; Xin Luo; Qingya Luo; Yuan Wang; Qinglv Wei; Yu Yang; Hongyan Zhao; Jing Xu; Wei Wang; Tao Liu; Ping Yi Cancer Res (2025) 85 (20): 3894–3909. Cancer Immunology（癌症免疫学） 8 Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy 达沙替尼重塑肿瘤微环境，使小细胞肺癌对免疫治疗敏感 Esther Redin; Nerea Otegui; Mirentxu Santos; Sergio Leon; Miriam Redrado; Diego Serrano; Eva Fernandez de Pierola; Joan Salvador Russo-Cabrera; Irene Ferrer; Maria Olmedo; Angel Diaz-Lagares; Maeva Houry; Silve Vicent; Anna Vilalta; Patricia Mondelo-Macía; Jorge García-González; Luis León-Mateos; Alvaro Gonzalez; Luis Paz-Ares; Rafael López; Miguel F. Sanmamed; Luis Montuenga; Alfonso Calvo Cancer Res (2025) 85 (20): 3910–3929. Cancer Metabolism and Molecular Mechanisms（癌症代谢与分子机制） 9 Exon Skipping of Ste20-Like Kinase Enhances Glycolysis and Tumor Progression by Activating Enolase 1–Mediated Phosphoenolpyruvate Production Ste20样激酶的外显子跳跃通过激活烯醇化酶1介导的磷酸烯醇式丙酮酸生成，增强糖酵解和肿瘤进展 Zeyu Chen; Jingyu Liao; Chang Zhu; Ruizhi Chang; Huifang Liang; Zeyang Ding; Zhao Huang; Xiaoping Chen; Junnan Liang; Bixiang Zhang Cancer Res (2025) 85 (20): 3930–3948. 10 PCBP2 Mediates Olaparib Resistance in Breast Cancer by Inhibiting m6A Methylation to Stabilize PARP1 mRNA PCBP2通过抑制m6A甲基化稳定PARP1 mRNA，介导乳腺癌对奥拉帕利的耐药性 Zhaochang Qi; Lifang He; Zemei Xu; Xi Luo; Likeng Ji; Chenting Lin; Armando E. Giuliano; Xiaojiang Cui; Zihao Deng; Jundong Wu; Stanley Li Lin; Yukun Cui Cancer Res (2025) 85 (20): 3949–3965. Therapeutic Development and Chemical Biology（治疗方法开发与生物化学） 11 TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11-Mutant Tumors to Anti–PD-1 Immunotherapy TNG260是一种小分子CoREST抑制剂，可使STK11突变肿瘤对抗PD-1免疫治疗敏感 Leanne G. Ahronian; Soumyadip Sahu; Minjie Zhang; Ayushi S. Patel; Ke Geng; Reshmee Bhattacharya; Gerald S. Falchook; Jonathan W. Goldman; Alexander I. Spira; Salman R. Punekar; David R. Spigel; Judy S. Wang; Ferdinandos Skoulidis; Janaye Stephens; Mary Meynardie; Jaylen M. Powell; Alfonso Lopez; Michela Ranieri; Magdalena A. Ploszaj; Yi Jer Tan; Yeuan Ting Lee; Yi Yu; Jiehui Deng; Ting Chen; Patrick McCarren; Alice Tsai; Suleman S. Hussain; Brian Doyon; Kenjie Amemiya; Jacques Ermolieff; Preksha Shahagadkar; Nikitha M. Das; Lauren R. Flynn; Julie A. Shields; Laney Danielczyk; Brian J. McMillan; Andre Mignault; Samuel R. Meier; Hsin-Jung Wu; David J. Guerin; Douglas A. Whittington; Chengyin Min; Iga Sienczylo; John P. Maxwell; Heather J. DiBenedetto; Hideo Watanabe; Brian B. Haines; Alan Huang; Adam Crystal; Jannik N. Andersen; Xinyuan Wu; Kwok-Kin Wong Cancer Res (2025) 85 (20): 3966–3982. Translational Cancer Biology（癌症转化生物学） 12 Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2−Breast Cancer 基于分型的精准治疗优化HR+/HER2−乳腺癌的传统“一刀切”疗法 Xiu-Zhi Zhu; Hu-Yun-Long Zhang; Yi-Fan Zhou; Yi-Yu Chen; Tong Fu; Ming-Liang Jin; Ya-Xin Zhao; Yi-Fan Xie; Xiaohua Zeng; Xi Jin; Yi-Zhou Jiang; Zhi-Ming Shao Cancer Res (2025) 85 (20): 3983–3998. 13 Targeting ATP7A-Dependent Copper Metabolic Homeostasis Induces Cuproptosis and Suppresses the Progression of Mutant KRAS-Driven Lung Cancer 靶向ATP7A依赖的铜代谢稳态诱导铜死亡，抑制突变KRAS驱动的肺癌进展 Jian Zhao; Weijie Zhang; Yuanyuan Zeng; Di Lu; Chenkang Ma; Mengzhu Zhang; Xin Cai; Zhifan Huang; Hongli Yang; Jianjun Li; Jianjie Zhu; Jian-An Huang; Zeyi Liu Cancer Res (2025) 85 (20): 3999–4017. Computational Cancer Biology and Technology（癌症计算生物学与技术） 14 Heterogeneous Driving Effects Guide Personalized Tumor Treatments Targeting N6-Methyladenosine 异质性驱动效应指导针对N6-甲基腺苷的个性化肿瘤治疗 Xudong Mao; Zhehao Xu; Xingbo Yang; Shihan Chen; Liyang Li; Zeyi Lu; Haohua Lu; Yudong Lin; Ruyue Wang; Yang Li; Fan Li; Lifeng Ding; Wenqin Luo; Xianjiong Chen; Yi Lu; Ziwei Zhu; Xinyu Zhao; Zhifan Ding; Liqun Xia; Qi Liu; Gonghui Li Cancer Res (2025) 85 (20): 4018–4035. Editor’s Notes（主编评注） 15 Editor’s Note: Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma 主编评注：昼夜节律基因Bmal1抑制舌鳞状细胞癌的肿瘤发生并增加对紫杉醇的敏感性 Qingming Tang; Bo Cheng; Mengru Xie; Yatao Chen; Jiajia Zhao; Xin Zhou; Lili Chen Cancer Res (2025) 85 (20): 4036. 16 Editor’s Note: MDR1 Synonymous Polymorphisms Alter Transporter Specificity and Protein Stability in a Stable Epithelial Monolayer 主编评注：MDR1同义多态性改变稳定上皮单层中转运蛋白的特异性和蛋白稳定性 King Leung Fung; James Pan; Shinobu Ohnuma; Paul E. Lund; Jessica N. Pixley; Chava Kimchi-Sarfaty; Suresh V. Ambudkar; Michael M. Gottesman Cancer Res (2025) 85 (20): 4037.